PRNP was linked to the negative regulation of type II interferon, IL-17, and IL-2 production along with negative regulation of the apoptotic process, suggesting its potential role in modulating immune responses and survival of synovial cells in RA. This evidence concerns the gene IL17A and rheumatoid arthritis.